What Are Wharton’s Jelly MSCs? A Scientific Guide to Allogeneic WJ-MSCs

What Is Wharton’s Jelly?
Wharton’s Jelly is a gelatinous connective tissue found inside the umbilical cord. This tissue, which surrounds and supports the blood vessels in the umbilical cord, contains various cell types.
WJ-MSCs are cells that can be isolated from this tissue. For this reason, they are referred to in the literature as Wharton’s Jelly-derived MSCs, or WJ-MSCs for short.
Biological Properties of WJ-MSCs
WJ-MSCs are technically classified within the mesenchymal stromal cell (MSC) group.
One of the main reasons for researching these cells is their ability to be cultured in a laboratory setting and their diverse biological properties. Research focuses particularly on the following properties:
• Their interactions with immune system cells
• Intercellular communication
• Secretion of biologically active molecules
• Mechanisms related to tissue repair and cellular responses
• Their ability to be cultured in a laboratory setting
Because of these characteristics, WJ-MSCs are being studied in relation to various diseases and biological processes.
However, it is not possible to directly conclude that a biological effect observed in a laboratory setting is effective in treating a specific disease in humans. Appropriate clinical trials are needed to evaluate clinical efficacy.
What Are Allogeneic WJ-MSCs?
“Allogeneic” means that the cells used are derived from a donor other than the person receiving the treatment or participating in the research.
In this approach, WJ-MSCs are derived from umbilical cord-derived tissue and undergo specific production and quality control processes.
The allogeneic WJ-MSC approach is considered a method that could enable the research and development of appropriately prepared cellular products, rather than obtaining separate cells for each patient.
However, the safety and suitability of an allogeneic cellular product cannot be determined solely by examining the cell source. Many factors—such as donor screening, production conditions, cell characterization, microbiological controls, and the intended use of the product—must be evaluated collectively.
Why Are Production and Quality Important?
WJ-MSC products are not automatically equivalent to one another.
When evaluating a cellular product, many stages of the production process are critical. These include:
• Screening of the donor for eligibility and infections
• Cell isolation method
• Cell culture and expansion conditions
• Determination of cell identity and characterization
• Cell viability
• Sterility and mycoplasma testing
• Endotoxin testing
• Genetic stability
• Assessments of cellular function or potency
• Storage, freezing, and thawing conditions
may be included.
Therefore, the statement “contains WJ-MSCs” alone does not provide sufficient information regarding a product’s quality or clinical suitability.
The Difference Between Research and Clinical Use
WJ-MSCs are being studied in preclinical and clinical research in relation to various diseases and biological processes.
However, the use of a cell or cellular product in research is not the same as its approval by regulatory agencies for the treatment of a specific disease.
Results obtained in clinical trials must be evaluated based on factors such as study design, patient population, characteristics of the cells used, method of administration, and follow-up period.
Therefore, when evaluating a WJ-MSC product, the following questions are important:
• For what purpose is the product being developed?
• In which clinical trials is it being studied?
• What are the characteristics of the cells used?
• How are the production and quality control processes conducted?
• Under which country’s or regulatory system’s jurisdiction is the product being evaluated?
• Is there official approval for the intended use?
Frequently Asked Questions
What are WJ-MSCs?
WJ-MSCs refer to cells derived from Wharton’s jelly tissue found in the umbilical cord. These cells are studied in the scientific literature under the category of mesenchymal stromal cells (MSCs).
Are WJ-MSCs stem cells?
In everyday and patient-focused communication, WJ-MSCs may be referred to as “Wharton’s Jelly stem cells.” However, technically, the term “MSC” is a more specific cellular designation. For this reason, it is important to use the term “mesenchymal stromal cells (MSC)” in scientific contexts.
What does allogeneic WJ-MSC mean?
Allogeneic WJ-MSCs refer to an approach in which the cells are obtained from a different donor rather than from the individual undergoing treatment or research.
For the treatment of which diseases are WJ-MSCs used?
WJ-MSCs are being researched in relation to many diseases and biological processes. However, the fact that they are being researched does not mean that they are a clinically proven or regulatory-approved treatment for a specific disease.
Are all WJ-MSC products identical?
No. Factors such as the source of the cells, isolation and production methods, culture conditions, cell characterization, quality controls, and storage conditions may vary between products.
What should be considered when evaluating a WJ-MSC product?
Information such as donor screening, cell identity and characterization, viability, sterility, mycoplasma, endotoxin, genetic stability, production conditions, and the product’s regulatory status should be evaluated collectively.
This content is for informational purposes only; it does not diagnose, recommend treatment, or guarantee results. Be sure to consult a doctor for a personalized evaluation.